1. Home
  2. MTR vs ADVB Comparison

MTR vs ADVB Comparison

Compare MTR & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTR
  • ADVB
  • Stock Information
  • Founded
  • MTR 1979
  • ADVB 2014
  • Country
  • MTR United States
  • ADVB United States
  • Employees
  • MTR N/A
  • ADVB N/A
  • Industry
  • MTR Oil & Gas Production
  • ADVB Medical Specialities
  • Sector
  • MTR Energy
  • ADVB Health Care
  • Exchange
  • MTR Nasdaq
  • ADVB Nasdaq
  • Market Cap
  • MTR 10.6M
  • ADVB 12.2M
  • IPO Year
  • MTR N/A
  • ADVB 2025
  • Fundamental
  • Price
  • MTR N/A
  • ADVB $0.47
  • Analyst Decision
  • MTR
  • ADVB
  • Analyst Count
  • MTR 0
  • ADVB 0
  • Target Price
  • MTR N/A
  • ADVB N/A
  • AVG Volume (30 Days)
  • MTR 2.8K
  • ADVB 258.4K
  • Earning Date
  • MTR 01-01-0001
  • ADVB 11-03-2025
  • Dividend Yield
  • MTR 3.24%
  • ADVB N/A
  • EPS Growth
  • MTR N/A
  • ADVB N/A
  • EPS
  • MTR 0.21
  • ADVB N/A
  • Revenue
  • MTR $580,337.00
  • ADVB N/A
  • Revenue This Year
  • MTR N/A
  • ADVB N/A
  • Revenue Next Year
  • MTR N/A
  • ADVB N/A
  • P/E Ratio
  • MTR $24.12
  • ADVB N/A
  • Revenue Growth
  • MTR N/A
  • ADVB N/A
  • 52 Week Low
  • MTR $4.70
  • ADVB $0.34
  • 52 Week High
  • MTR $10.42
  • ADVB $4.10
  • Technical
  • Relative Strength Index (RSI)
  • MTR 32.96
  • ADVB 50.82
  • Support Level
  • MTR $5.12
  • ADVB $0.43
  • Resistance Level
  • MTR $5.34
  • ADVB $0.65
  • Average True Range (ATR)
  • MTR 0.14
  • ADVB 0.05
  • MACD
  • MTR -0.05
  • ADVB 0.00
  • Stochastic Oscillator
  • MTR 0.00
  • ADVB 28.15

About MTR Mesa Royalty Trust

Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.

About ADVB Advanced Biomed Inc. Common Stock

Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: